PM360

JUNE 24, 2024

According to a recent industry survey, over 70% of patients feel that the healthcare system falls short of meeting their needs in some capacity, and 64% expect their healthcare providers to have a better understanding of their health journey. million by 2028.

Physicians 59

Physicians Patients Healthcare Provider Healthcare 59

Nixon Gwilt Law

MAY 26, 2023

Digital health companies building VR solutions often ask us this question, and if you are a founder or executive looking for ways to commercialize your VR platform for healthcare providers in the U.S., their home) and transmit that information to the patient’s healthcare provider in another location (e.g., Telehealth.

Healthcare 119

Healthcare Healthcare Marketing Healthcare Provider 119

pharmaphorum

JANUARY 5, 2023

Everything from transitioning to virtual meetings with healthcare providers, to navigating the logistics of supply chain disruptions, has permanently altered pharma operations – many would say for the better. Address mental health early: Burnout is common amongst professionals in the pharmaceutical industry and leads to high turnover.

Pharmaceutical 88

Pharmaceutical Recruitment Training Education 88

Every Ancillary

MAY 14, 2021

That being said, the clinical laboratory market is expected to see growth of nearly 40% by 2028. Delivers real clinical value leading to more effective treatment plans. EKRA has changed the way marketers are compensated by labs, which has led to many abandoning this sector all together. Generous compensation.

Medical sales 52

Medical sales Medical Sales Insurance 52

PM360

APRIL 7, 2023

However, Medicare will only be able to negotiate prices for 10 Part D drugs in 2026, another 15 Part D drugs in 2027, another 15 Part D and Part B drugs in 2028, and another 20 Part D and Part B drugs for 2029 and subsequent years. It’s amazing we still separate the drug costs from overall healthcare costs,” Sontupe says.

Marketing 52

Marketing Pharma Manufacturing Healthcare 52

Pharmaceutical Representative Training

JANUARY 29, 2025

The existence of biosimilars is meant to address both the cost and access of biologics in the healthcare industry. [1] Companies will have to make an effort to communicate with these healthcare professionals, informing them of their product and helping them feel more confident in recommending it to their patients.

Marketing 52

Marketing Healthcare Healthcare Physicians 52

pharmaphorum

OCTOBER 10, 2022

Because it was a new service, people were concerned that it was a scam or just another flyer to put in the bin,” explains Jane Derbyshire, lung project lead for RM Partners West London Cancer Alliance. The goal set out by the NHSE Long Term Plan is ambitions: to have three quarters of cancers diagnosed at an early stage by 2028.

Patients 98

Patients Pharma Media Training 98